Literature DB >> 23167641

Debating the clinical utility of direct-to-consumer genetic testing for addiction susceptibility.

Pascal Borry1, Lidewij Henneman.   

Abstract

Mesh：

Year:  2012        PMID： 23167641     DOI： 10.1111/j.1360-0443.2012.03939.x

Source DB:  PubMed          Journal:  Addiction        ISSN： 0965-2140            Impact factor:   6.526


× No keyword cloud information.
  2 in total

1.  The value of genetic testing: beyond clinical utility.

Authors:  Barbara Lerner; Nell Marshall; Sabine Oishi; Andrew Lanto; Martin Lee; Alison B Hamilton; Elizabeth M Yano; Maren T Scheuner
Journal:  Genet Med       Date:  2016-12-15       Impact factor: 8.822

2.  Medicine, market and communication: ethical considerations in regard to persuasive communication in direct-to-consumer genetic testing services.

Authors:  Manuel Schaper; Silke Schicktanz
Journal:  BMC Med Ethics       Date:  2018-06-05       Impact factor: 2.652
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.